Mi-Sun Won

Title: Mi-Sun Won: Innovator in HIF-1α Inhibitors

Introduction

Mi-Sun Won is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that act as HIF-1α inhibitors. With a total of 2 patents to her name, her work has the potential to impact the treatment of various cancers and other medical conditions.

Latest Patents

Mi-Sun Won's latest patents focus on novel compounds that serve as HIF-1α inhibitors. These compounds are designed to inhibit the activity of HIF-1α, which plays a crucial role in the progression of solid tumors such as colon cancer, liver cancer, stomach cancer, and breast cancer. Additionally, her inventions are aimed at providing therapeutic options for conditions like diabetic retinopathy and rheumatoid arthritis, which are exacerbated by HIF-1α-mediated VEGFA expression.

Career Highlights

Throughout her career, Mi-Sun Won has been associated with notable institutions such as the Dongguk University Industry-Academic Cooperation Foundation and the Korea Research Institute of Bioscience and Biotechnology. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.

Collaborations

Mi-Sun Won has collaborated with esteemed colleagues, including Kyeong Seok Lee and Hwan-Mook Kim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her research endeavors.

Conclusion

Mi-Sun Won is a dedicated inventor whose work on HIF-1α inhibitors holds promise for advancing cancer treatment and addressing other significant health issues. Her contributions to the field of pharmaceutical sciences are noteworthy and continue to inspire future innovations.